During 1994 and 1995, the prevalence of hepatitis C virus (HCV) and its genotypes were studied in several rural and urban populations in three West African countries: Guinea, Burkina Faso, and Benin. The following groups were screened for antibodies to HCV (anti-HCV): 459 villagers in the forest reg
High level of hepatitis C endemicity in Gabon, equatorial Africa
✍ Scribed by Eric Delaporte; Valérie Thiers; Marie Christine Dazza; Raffaella Romeo; Najoua Mlika-Cabanne; Isabelle Aptel; Dirk Schrijvers; Christian Bréchet; Bernard Larouzé
- Publisher
- Elsevier Science
- Year
- 1993
- Tongue
- English
- Weight
- 290 KB
- Volume
- 87
- Category
- Article
- ISSN
- 0035-9203
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Hepatitis C (HCV) molecular epidemiology is documented poorly in central African countries. In response to this, a population‐based study of 319 consenting adults resident in a remote village of Gabon was undertaken (mean age: 38 years; age range: 13–85+; sex ratio: 0.74). Screening for
Mass screening for hepatitis C virus antibody was carried out in 875 inhabitants (313 men and 562 women) of a town in Japan with a high rate of hepatitis B virus infection. The overall rate of positivity for anti-HCV was 8.8% (6.4% in men and 10.1% in women). The rate of positivity for hepatitis B v
To assess the clinical relevance of transforming growth factor beta1 (TGF-beta1) in chronic liver disease, urinary TGF-beta1 and circulating aminoterminal propeptides of type III procollagen (PIIINP) levels were determined by radioimmunoassay in 100 cirrhotic patients, 44 patients with chronic hepat
Many studies have demonstrated in animal experiments that persistent inflammation may accelerate the development of carcinoma. In this article, the question of whether the persistent elevation of serum alanine aminotransferase (ALT) levels (which represents the inflammatory necrosis of hepatocytes)